Novozymes A/S 

kr397.40
215
-kr1.20-0.3%Tuesday 15:59

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
36.49
Dividend Yield
1.51%
Dividend
5.98

Upcoming

Dividends

1.51%Dividend Yield
Oct 2023
kr4.20
Mar 2023
kr6.00
Mar 2022
kr5.50
Mar 2021
kr5.25
Mar 2020
kr5.25
10Y Growth
10.55%
5Y Growth
5.92%
3Y Growth
4.55%
1Y Growth
9.09%

Earnings

Nov 5Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
2.73
4.39
6.05
7.71
Expected EPS
5.34918664984
Actual EPS
N/A

Financials

20.94%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
17.55BRevenue
3.68BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global pharmaceutical company that competes with Novonesis AS in the development and marketing of medications and vaccines for various diseases, including those in areas where Novonesis may operate.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a leading healthcare company that develops innovative pharmaceuticals and vaccines, directly competing with Novonesis AS in several therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diversified healthcare giant that competes with Novonesis AS through its pharmaceutical division, developing drugs that may overlap with Novonesis' product portfolio.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company that competes with Novonesis AS in the pharmaceutical and healthcare market, particularly in the development of vaccines and medications.
Novartis
NVS
Mkt Cap268B
Novartis is a multinational pharmaceutical company that competes with Novonesis AS in researching, developing, manufacturing, and marketing a wide range of healthcare products.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company that competes with Novonesis AS in the discovery, development, and commercialization of new medicines and therapies.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Novonesis AS in the development of prescription pharmaceuticals in several therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Novonesis AS in the pharmaceutical and diagnostics industries, focusing on oncology, immunology, and infectious diseases.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is a global healthcare leader that competes with Novonesis AS in the development and marketing of therapeutic solutions in areas such as rare diseases, multiple sclerosis, and oncology.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Novonesis AS in the discovery, development, and commercialization of prescription medicines, particularly in the oncology sector.

About

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Show More
CEO
Ms. Ester Baiget
Employees
6397
Country
Denmark
ISIN
DK0060336014
WKN
000A1JP9Y

Listings

0 Comments

Share your thoughts

FAQs

What is Novozymes A/S stock price today?▼
The current price of NZYM-B.CO is kr397.40 DKK — it has decreased by -0.3% in the past 24 hours. Watch Novozymes A/S stock price performance more closely on the chart.
What is Novozymes A/S stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Copenhagen Exchange exchange Novozymes A/S stocks are traded under the ticker NZYM-B.CO.
What is Novozymes A/S revenue for the last year?▼
Novozymes A/S revenue for the last year amounts to 17.55B DKK.
What is Novozymes A/S net income for the last year?▼
NZYM-B.CO net income for the last year is 3.68B DKK.
Does Novozymes A/S pay dividends?▼
Yes, NZYM-B.CO dividends are paid annual. The last dividend per share was 4.2 . As of today, Dividend Yield (FWD)% is 1.51%.
How many employees does Novozymes A/S have?▼
As of October 18, 2026, the company has 6,397 employees.
In which sector is Novozymes A/S located?▼
Novozymes A/S operates in the Materials sector.
When did Novozymes A/S complete a stock split?▼
Novozymes A/S has not had any recent stock splits.
Where is Novozymes A/S headquartered?▼
Novozymes A/S is headquartered in Bagsvaerd, Denmark.